BioNTech vs Nimbus Therapeutics
BioNTech vs Nimbus Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioNTech is on 66/100 and Nimbus Therapeutics on 51/100.
Where each one leads
BioNTech
- our overall score: 66/100 against 51/100
- agent readiness: 40/100 against 27/100
- domain rating: 74/100 against 55/100
- funding raised: $975M against $589M
Nimbus Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | BioNTech | Nimbus Therapeutics |
|---|---|---|
| What it is | Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases. | Nimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotechnology, Drug Discovery, AI, Machine Learning |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotechnology | Services |
| Founded | 2008 | 2009 |
| Headquarters | Mainz, Germany | Boston, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BioNTech | Nimbus Therapeutics |
|---|---|---|
| Employees | 5,128 | Not published |
| Total funding | $975M | $589M |
| Latest round | Loan | Series F |
| LinkedIn followers | 295,812 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioNTech | Nimbus Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 66/100 | 51/100 |
| Traction | 60/100 | 40/100 |
| Team | 70/100 | 30/100 |
| Community | Not published | 8/100 |
| Search visibility | 35/100 | 18/100 |
| Quality | 78/100 | 70/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | F (27/100) |
| Domain ratingLink authority, 0-100 | 74/100 | 55/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioNTech | Nimbus Therapeutics |
|---|---|---|
| Hosting | Azure | Google Cloud |
| CMS | Not detected | WordPress |
| Analytics | Google Tag Manager | Google Analytics 4, Segment, Microsoft Clarity |
BioNTech vs Nimbus Therapeutics: common questions
Which is better, BioNTech or Nimbus Therapeutics?
On our 0-100 score BioNTech rates higher (66/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do BioNTech and Nimbus Therapeutics compare on the numbers?
BioNTech leads on our overall score (66/100 against 51/100), agent readiness (40/100 against 27/100), domain rating (74/100 against 55/100), funding raised ($975M against $589M).
Read the full BioNTech review and pricing or the Nimbus Therapeutics review and pricing. You can also browse other BioNTech alternatives we track.